Abingdon Health Plc

Equities

ABDX

GB00BLF79J41

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 11:35:26 2024-05-31 EDT			5-day change	1st Jan Change
10.75 ^GBX	-.--%		-2.27%	-2.27%

05-15	Abingdon pregnancy self-tests now available under the Boots brand	AN
05-15	Abingdon Health Plans UK Launch of Saliva Pregnancy Test Product for Spring	MT

Abingdon pregnancy self-tests now available under the Boots brand

May 15, 2024 at 09:30 am

(Alliance News) - Abingdon Health PLC on Wednesday said its saliva pregnancy self test is now available across the UK and online.

The tests, which have been developed in partnership Salignostics and Crest Medical Ltd, will be sold as a Boots UK Ltd own brand product.

By 2033 the UK pregnancy self-test market is expected to reach USD56.7 million.

Chief Executive Officer Chris Yates commented: "This launch showcases our ability to deliver innovative and disruptive private label products through our...lateral flow full-service proposition with one of the most trusted UK brands - Boots."

Abingdon shares were up 10% to 10.72 pence each in London on Wednesday afternoon.

By Elijah Dale, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Latest news about Abingdon Health Plc

Abingdon pregnancy self-tests now available under the Boots brand	05-15	AN
Abingdon Health Plans UK Launch of Saliva Pregnancy Test Product for Spring	05-15	MT
Abingdon Health Plc acquired Ivdeology Holdings Ltd for £0.7 million.	05-06	CI
Peel Hunt's RetailBook raises GBP2.5 million	03-25	AN
Abingdon Health Completes Design Freeze for STD Self-Tests	03-25	MT
Abingdon Health to Provide Rapid Self-tests to Boots	03-20	MT
Abingdon Health strikes deal amidst upswing in self testing market	03-20	AN
AIM WINNERS & LOSERS: Abingdon Health rises on Boots agreement	03-20	AN
AIM WINNERS & LOSERS: Smartspace backs Sign In bid; Abingdon jumps	03-14	AN
London stocks tread water with US data to come	03-14	AN
ABINGDON HEALTH PLC: BOARD EXPECTS THAT H2 REVENUE WILL BE SIGN…	03-14	RE
Abingdon Health plc Provides Earnings Guidance for the Second Half and Full Fiscal Year 2024	03-14	CI
Abingdon Health Plc Reports Earnings Results for the Half Year Ended December 31, 2023	03-14	CI
Abingdon Health shares down despite decent interim results	01-11	AN
Abingdon Health Plc Announces Promotion of Laura Towse as Group Financial Controller	01-11	CI
Abingdon Health plc Announces Resignation of Andrew Feather as Interim Finance Director	01-11	CI
Abingdon Health Plc Reports Revenue Results for the Six Months Ended December 31, 2023	01-11	CI
Abingdon expects higher half-year revenue	12-15	AN
Stocks edge higher ahead of slew of PMIs	12-15	AN
FTSE 100 Closes Up on Tech Earnings Expectations, Easing Bond Yields	23-10-24	DJ
Abingdon Health appoints Feather as new interim finance director	23-10-24	AN
Abingdon Health Names Interim Finance Director	23-10-24	MT
Abingdon Health Plc Announces Executive Changes	23-10-24	CI
FTSE 100 Closes Down 1.1% on Middle East Tensions	23-10-18	DJ
Abingdon Health finance chief resigns, seeks interim hire	23-10-18	AN

Chart Abingdon Health Plc

Duration

Period

More charts

Company Profile

Abingdon Health plc provides lateral flow contract development and manufacturing (CDMO services) and related contract services to an international customer base. It offers its services to an international customer base across industry sectors, which include clinical, self-testing, animal health, plant health, and environmental testing. Its segments include Product sales, Contract manufacturing, Contract development, and Regulatory. Its regulatory services include technical file build, regulatory filing support, implementation of quality management systems and quality assurance. The Companyâs CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-11-13 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
ABINGDON HEALTH PLC	-2.27%	42.81M
BIOMÉRIEUX	-3.43%	12.45B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.17%	8.22B
LANTHEUS HOLDINGS, INC.	+31.98%	5.67B
AUTOBIO DIAGNOSTICS CO., LTD.	-10.03%	4.11B
10X GENOMICS, INC.	-59.94%	2.68B
ANDON HEALTH CO., LTD.	+11.23%	2.68B
VITROLIFE AB	-5.14%	2.37B
MYRIAD GENETICS, INC.	+18.91%	2.06B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-7.56%	1.8B

Diagnostic & Testing Substances